## Note
nid: 1495635392036
model: AnKingOverhaul
tags: #AK_Original_Decks::Step_1::Zanki_Pharmacology, #AK_Step1_v11::#B&B::12_Immunology::03_Pharm::02_Immunosuppressive_Drugs, #AK_Step1_v11::#FirstAid::02_Immunology::04_Immunosuppressants::01_Immunosuppressants, #AK_Step1_v11::#FirstAid::02_Immunology::04_Immunosuppressants::01_Immunosuppressants::Sirolimus/Rapamycin, #AK_Step1_v11::#OME_banner::Basic_Science::07_Immunology, #AK_Step1_v11::#Physeo::09_Pharm::01_Immunology::03_Sirolimus, #AK_Step1_v11::#Pixorize::01_Immunology::09_Immunosuppressants::03_Sirolimus_(Rapamycin), #AK_Step1_v11::#SketchyPharm::Immunology-&-Biochemistry-Pharmacology::Immuno-suppressives::Transplant-Rejection-Prophylaxis, #AK_Step1_v11::^Other::^EXPN, #AK_Step1_v11::^Other::^HighYield::1-HighYield
markdown: false

### Text
<div>
  <b>Sirolimus</b> works by binding <b>{{c1::FKBP}}</b>, which
  <u>inhibits</u> the {{c2::<b>mTOR::specific signal</b>}}
  signalling complex involved in cell growth
</div>

### Extra
<div>
  <i>- Important, when FKBP is bound by Tacrolimus the complex
  inhibits calcineurin, BUT when bound by Sirolimus the complex
  inhibits the mTOR Complex I</i>
</div>
<div>
  <i><img src="IndianDermatolOnlineJ_2013_4_1_54_105488_u2.jpg"
  draggable="false"></i>
</div>
<div>
  <i>- mTORC1 is a complex of <u>mTOR and various adaptor
  proteins</u> that will activate different pathways based on
  different intracellular cues detected by the complex (i.e.
  Certain cues will stimulate cell growth, other cues will
  stimulate autophagy, etc.)</i>
</div>

### Lecture Notes


### Missed Questions


### Pathoma


### Boards and Beyond


### First Aid


### Sketchy


### Pixorize


### Physeo


### OME
<div class="ome-widget">
  <a href=
  "https://onlinemeded.org/spa/immunology?ref=anki"><img src=
  "_OME_AnkiFlashcards_Topic_6.png"></a>
</div>

### Additional Resources


### One by one

